glp 1 patch research GLP-1 Patches: What are They, How They Work, Side Effects & More GLP-1 Patch™ – Medical Weight
Description
& Singh, P
Currently, only about 9% of commercial plans provide unrestricted coverage for Wegovy, and just 4% do so for Zepbound , according to GoodRx tracking data
Novo Nordisk Headquarters: Bagsvrd, Denmark Number of employees: 77,000 Year founded: 1923 Revenue (2025): $42.1 billion Forbes overall rank: 42 In 2025, Novo Nordisk reported full-year sales of about DKK 309.1 billion (roughly $45 billion), a ~6% increase in Danish kroner and ~10% at constant exchange rates, driven mainly by obesity and diabetes semaglutide products Wegovy and Ozempic, though operating profit growth was modest and weighed down by transformation costs and pricing pressures
Hirasawa et al
Always consult with a healthcare professional for personalized guidance
